Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa7
|
ENSMUSG00000038236.6 | homeobox A7 |
Hoxc8
|
ENSMUSG00000001657.6 | homeobox C8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52220490_52220729 | Hoxa7 | 216 | 0.769781 | -0.12 | 4.0e-01 | Click! |
chr6_52222050_52222610 | Hoxa7 | 476 | 0.490362 | -0.09 | 5.1e-01 | Click! |
chr6_52217759_52218068 | Hoxa7 | 408 | 0.553393 | -0.07 | 6.0e-01 | Click! |
chr6_52221373_52222006 | Hoxa7 | 165 | 0.822309 | -0.05 | 7.3e-01 | Click! |
chr6_52217490_52217690 | Hoxa7 | 85 | 0.883448 | -0.03 | 8.2e-01 | Click! |
chr15_102990487_102990674 | Hoxc8 | 27 | 0.940617 | -0.23 | 8.7e-02 | Click! |
chr15_102987561_102987746 | Hoxc8 | 2954 | 0.109034 | -0.12 | 3.7e-01 | Click! |
chr15_102991243_102991394 | Hoxc8 | 571 | 0.530873 | -0.11 | 4.2e-01 | Click! |
chr15_102990790_102991182 | Hoxc8 | 379 | 0.695569 | -0.08 | 5.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_47909349_47909983 | 50.31 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr3_144198270_144199266 | 32.25 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr15_79690079_79691459 | 30.97 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr2_105769867_105770156 | 26.93 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr3_144174293_144174609 | 25.98 |
Lmo4 |
LIM domain only 4 |
20367 |
0.17 |
chr6_138424907_138425582 | 23.74 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr13_97825475_97826241 | 23.66 |
Gm41031 |
predicted gene, 41031 |
27 |
0.98 |
chr1_12409934_12410455 | 22.86 |
Mir6341 |
microRNA 6341 |
15792 |
0.23 |
chr3_157732464_157732921 | 21.06 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr4_116720426_116721428 | 19.97 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr13_43480925_43481874 | 19.67 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr19_24535123_24535505 | 18.80 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
20475 |
0.18 |
chr14_48418768_48419083 | 18.55 |
Gm3534 |
predicted pseudogene 3534 |
10307 |
0.15 |
chr15_82794220_82794587 | 18.17 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr18_3005171_3005609 | 17.25 |
Gm50072 |
predicted gene, 50072 |
10518 |
0.21 |
chr14_8286642_8286923 | 16.95 |
Fam107a |
family with sequence similarity 107, member A |
22995 |
0.16 |
chr1_162216776_162217075 | 16.89 |
Dnm3os |
dynamin 3, opposite strand |
698 |
0.48 |
chr1_24612739_24612914 | 16.17 |
Gm10222 |
predicted gene 10222 |
126 |
0.59 |
chr6_55901966_55902527 | 16.01 |
Itprid1 |
ITPR interacting domain containing 1 |
15421 |
0.27 |
chr4_150685197_150685518 | 15.94 |
Gm16079 |
predicted gene 16079 |
6565 |
0.21 |
chr16_72699156_72700074 | 15.79 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr2_103466992_103467253 | 15.60 |
Cat |
catalase |
18003 |
0.16 |
chr12_24746783_24747204 | 14.77 |
Gm48895 |
predicted gene, 48895 |
13232 |
0.11 |
chr10_63199151_63199302 | 14.66 |
Mypn |
myopalladin |
4726 |
0.16 |
chr7_109174643_109175577 | 14.66 |
Lmo1 |
LIM domain only 1 |
97 |
0.97 |
chr7_40842646_40842992 | 14.30 |
Gm45008 |
predicted gene 45008 |
21709 |
0.13 |
chr15_96874188_96874389 | 14.28 |
Rpl10a-ps3 |
ribosomal protein L10A, pseudogene 3 |
49117 |
0.16 |
chr4_109210927_109211213 | 14.23 |
Osbpl9 |
oxysterol binding protein-like 9 |
8798 |
0.2 |
chr9_58658414_58658568 | 14.18 |
Rec114 |
REC114 meiotic recombination protein |
801 |
0.62 |
chr10_21295422_21295685 | 14.11 |
Hbs1l |
Hbs1-like (S. cerevisiae) |
426 |
0.79 |
chr19_43767999_43768210 | 14.03 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr11_103132227_103133103 | 13.87 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
chr3_121530937_121531224 | 13.82 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
539 |
0.67 |
chr2_153560652_153561518 | 13.56 |
Nol4l |
nucleolar protein 4-like |
31114 |
0.15 |
chr4_19926174_19926326 | 13.54 |
Atp6v0d2 |
ATPase, H+ transporting, lysosomal V0 subunit D2 |
3645 |
0.26 |
chr5_107837205_107837356 | 13.45 |
Evi5 |
ecotropic viral integration site 5 |
200 |
0.89 |
chr1_68666889_68667107 | 13.42 |
Gm37735 |
predicted gene, 37735 |
26169 |
0.2 |
chr18_56871340_56871513 | 13.38 |
Gm18087 |
predicted gene, 18087 |
44662 |
0.14 |
chr11_30648868_30649937 | 13.17 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr11_4094091_4094832 | 13.10 |
Mtfp1 |
mitochondrial fission process 1 |
679 |
0.5 |
chr5_112001700_112002600 | 12.91 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr15_77153510_77154116 | 12.86 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
1 |
0.97 |
chr17_35741597_35741789 | 12.86 |
Gm20443 |
predicted gene 20443 |
1887 |
0.16 |
chr8_128688649_128689204 | 12.68 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
3056 |
0.24 |
chr8_120549369_120550473 | 12.67 |
Mir7687 |
microRNA 7687 |
11225 |
0.1 |
chr1_105088844_105089211 | 12.62 |
Gm29012 |
predicted gene 29012 |
27427 |
0.23 |
chr1_184290010_184290162 | 12.56 |
Gm37223 |
predicted gene, 37223 |
68243 |
0.11 |
chr3_103171228_103172264 | 12.10 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr9_108338578_108339700 | 12.06 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr3_6887007_6887616 | 12.06 |
Gm22074 |
predicted gene, 22074 |
89957 |
0.09 |
chr2_146099017_146099372 | 12.01 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr4_117682587_117682738 | 11.97 |
Dmap1 |
DNA methyltransferase 1-associated protein 1 |
389 |
0.81 |
chr17_40810907_40811196 | 11.96 |
Rhag |
Rhesus blood group-associated A glycoprotein |
75 |
0.96 |
chr8_104374837_104375423 | 11.96 |
Gm45877 |
predicted gene 45877 |
11462 |
0.09 |
chr18_4636780_4636931 | 11.93 |
Jcad |
junctional cadherin 5 associated |
1977 |
0.4 |
chr6_30693996_30694444 | 11.82 |
Cep41 |
centrosomal protein 41 |
471 |
0.72 |
chr5_76828559_76829372 | 11.79 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
11634 |
0.19 |
chr8_120539785_120540192 | 11.77 |
Mir7687 |
microRNA 7687 |
1292 |
0.27 |
chr9_66181229_66181417 | 11.69 |
Dapk2 |
death-associated protein kinase 2 |
23088 |
0.17 |
chr4_155213419_155213944 | 11.55 |
Ski |
ski sarcoma viral oncogene homolog (avian) |
8854 |
0.18 |
chr7_109191268_109192295 | 11.49 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr1_131446984_131447348 | 11.49 |
Gm29487 |
predicted gene 29487 |
529 |
0.74 |
chr3_143078355_143078668 | 11.48 |
Gm43614 |
predicted gene 43614 |
29437 |
0.18 |
chr17_83659006_83659302 | 11.39 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr11_49713043_49713524 | 11.31 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr10_84886211_84886658 | 11.22 |
Ric8b |
RIC8 guanine nucleotide exchange factor B |
31182 |
0.17 |
chr3_55075221_55075624 | 11.17 |
Gm43555 |
predicted gene 43555 |
17766 |
0.13 |
chr17_79077658_79077809 | 11.09 |
Qpct |
glutaminyl-peptide cyclotransferase (glutaminyl cyclase) |
731 |
0.65 |
chrX_133653163_133653401 | 11.08 |
Pcdh19 |
protocadherin 19 |
31709 |
0.23 |
chr4_103189337_103189489 | 11.03 |
Slc35d1 |
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
25259 |
0.14 |
chr1_132190710_132192438 | 11.02 |
Gm29695 |
predicted gene, 29695 |
117 |
0.49 |
chr9_65826224_65827697 | 11.02 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr15_75593188_75593349 | 10.99 |
Gpihbp1 |
GPI-anchored HDL-binding protein 1 |
3360 |
0.15 |
chr5_144313725_144313894 | 10.97 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
24902 |
0.13 |
chr13_9019634_9019841 | 10.95 |
Gtpbp4 |
GTP binding protein 4 |
23654 |
0.1 |
chr9_88483752_88484150 | 10.92 |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
1377 |
0.28 |
chr13_4206238_4206406 | 10.79 |
Akr1c13 |
aldo-keto reductase family 1, member C13 |
12464 |
0.13 |
chr10_63060801_63060952 | 10.74 |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
147 |
0.91 |
chr2_84455296_84455508 | 10.57 |
Tfpi |
tissue factor pathway inhibitor |
2708 |
0.26 |
chr13_64155195_64155660 | 10.51 |
Zfp367 |
zinc finger protein 367 |
2225 |
0.18 |
chr2_174291748_174291899 | 10.51 |
Gnasas1 |
GNAS antisense RNA 1 |
3566 |
0.16 |
chr5_60042722_60043044 | 10.45 |
Gm43393 |
predicted gene 43393 |
17000 |
0.17 |
chr13_91890302_91890496 | 10.45 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
13514 |
0.2 |
chr9_103288790_103289055 | 10.43 |
1300017J02Rik |
RIKEN cDNA 1300017J02 gene |
625 |
0.69 |
chr14_60635928_60636079 | 10.40 |
Spata13 |
spermatogenesis associated 13 |
1248 |
0.53 |
chr6_67161663_67162061 | 10.40 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr11_113014293_113014953 | 10.34 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
158454 |
0.04 |
chr9_70935136_70935406 | 10.33 |
Lipc |
lipase, hepatic |
463 |
0.83 |
chr6_72097140_72098281 | 10.30 |
St3gal5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
47 |
0.96 |
chr1_191641396_191641769 | 10.30 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr11_100938783_100940230 | 10.29 |
Stat3 |
signal transducer and activator of transcription 3 |
27 |
0.97 |
chr1_21660699_21661216 | 10.28 |
Gm7658 |
predicted gene 7658 |
147901 |
0.04 |
chr17_56036249_56036917 | 10.27 |
Sh3gl1 |
SH3-domain GRB2-like 1 |
7 |
0.94 |
chr7_4739300_4740219 | 10.23 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr6_120619174_120619360 | 10.21 |
Gm44124 |
predicted gene, 44124 |
39091 |
0.11 |
chr10_128779498_128779802 | 10.15 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chr11_69585627_69586063 | 10.09 |
Trp53 |
transformation related protein 53 |
2850 |
0.09 |
chr19_5845343_5846183 | 10.08 |
Frmd8os |
FERM domain containing 8, opposite strand |
140 |
0.66 |
chr7_44472278_44472749 | 10.07 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
1025 |
0.24 |
chr2_170158021_170158172 | 9.99 |
Zfp217 |
zinc finger protein 217 |
9993 |
0.28 |
chr17_78290588_78290739 | 9.94 |
Crim1 |
cysteine rich transmembrane BMP regulator 1 (chordin like) |
10480 |
0.18 |
chr11_90663400_90663551 | 9.90 |
Tom1l1 |
target of myb1-like 1 (chicken) |
163 |
0.96 |
chr7_108797287_108797500 | 9.85 |
Gm45232 |
predicted gene 45232 |
2390 |
0.19 |
chr5_115436438_115437458 | 9.85 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr6_67481043_67481194 | 9.83 |
Il23r |
interleukin 23 receptor |
10737 |
0.15 |
chr1_177475904_177476057 | 9.82 |
Gm37306 |
predicted gene, 37306 |
8602 |
0.17 |
chr5_146680717_146680936 | 9.75 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
25796 |
0.15 |
chr19_55194224_55194541 | 9.72 |
Mir6715 |
microRNA 6715 |
1704 |
0.31 |
chr3_100166988_100167289 | 9.63 |
Gdap2 |
ganglioside-induced differentiation-associated-protein 2 |
4594 |
0.21 |
chr7_143340680_143341191 | 9.61 |
Gm38095 |
predicted gene, 38095 |
3502 |
0.17 |
chr17_84153970_84154239 | 9.59 |
Gm19696 |
predicted gene, 19696 |
2322 |
0.26 |
chr14_71174453_71174604 | 9.58 |
Gm4251 |
predicted gene 4251 |
76745 |
0.1 |
chr4_97777645_97778418 | 9.58 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
17 |
0.72 |
chr12_72437630_72438246 | 9.56 |
Lrrc9 |
leucine rich repeat containing 9 |
3928 |
0.24 |
chr7_126975552_126976438 | 9.55 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr15_98608664_98610204 | 9.50 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr9_63668747_63668919 | 9.49 |
Smad3 |
SMAD family member 3 |
2286 |
0.32 |
chr5_120577025_120577195 | 9.47 |
Tpcn1 |
two pore channel 1 |
11484 |
0.09 |
chr6_52190902_52191308 | 9.46 |
Hoxa4 |
homeobox A4 |
648 |
0.36 |
chr4_132470179_132470330 | 9.39 |
Med18 |
mediator complex subunit 18 |
6333 |
0.11 |
chr3_118566700_118566851 | 9.37 |
Dpyd |
dihydropyrimidine dehydrogenase |
4589 |
0.21 |
chr13_52822783_52823147 | 9.34 |
BB123696 |
expressed sequence BB123696 |
65760 |
0.12 |
chr2_172448720_172448871 | 9.33 |
Rtf2 |
replication termination factor 2 |
4182 |
0.15 |
chr10_93886358_93886509 | 9.30 |
Metap2 |
methionine aminopeptidase 2 |
1053 |
0.42 |
chr8_26656438_26656991 | 9.28 |
Gm32098 |
predicted gene, 32098 |
11592 |
0.16 |
chr12_105011234_105011388 | 9.28 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
1502 |
0.25 |
chr5_115977292_115977636 | 9.26 |
Cit |
citron |
9439 |
0.15 |
chr3_121264351_121264701 | 9.20 |
Tlcd4 |
TLC domain containing 4 |
1186 |
0.4 |
chr10_121493050_121493221 | 9.19 |
Gm40787 |
predicted gene, 40787 |
4149 |
0.13 |
chr10_53382724_53383006 | 9.18 |
Cep85l |
centrosomal protein 85-like |
2918 |
0.17 |
chrX_11806986_11807843 | 9.15 |
Gm26314 |
predicted gene, 26314 |
43070 |
0.16 |
chr13_63496923_63497254 | 9.10 |
Fancc |
Fanconi anemia, complementation group C |
190 |
0.93 |
chr13_23744597_23744910 | 9.09 |
H3c3 |
H3 clustered histone 3 |
849 |
0.2 |
chr10_13240589_13240802 | 9.09 |
Gm47402 |
predicted gene, 47402 |
35469 |
0.15 |
chr1_40229820_40230069 | 9.06 |
Il1r1 |
interleukin 1 receptor, type I |
4864 |
0.22 |
chr2_125278458_125278642 | 9.04 |
A530010F05Rik |
RIKEN cDNA A530010F05 gene |
3986 |
0.2 |
chr3_82809967_82810130 | 9.03 |
Gm43348 |
predicted gene 43348 |
2186 |
0.32 |
chr1_130681895_130682046 | 9.00 |
C4bp-ps1 |
complement component 4 binding protein, pseudogene 1 |
2101 |
0.19 |
chr5_137349031_137350198 | 8.93 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr7_103915106_103915263 | 8.92 |
Olfr65 |
olfactory receptor 65 |
8842 |
0.06 |
chr16_93197838_93198066 | 8.92 |
Gm28003 |
predicted gene, 28003 |
125197 |
0.05 |
chr14_21096598_21096812 | 8.92 |
Adk |
adenosine kinase |
20553 |
0.2 |
chr5_148897060_148897772 | 8.90 |
Katnal1 |
katanin p60 subunit A-like 1 |
18337 |
0.11 |
chr7_97356495_97356646 | 8.86 |
Alg8 |
asparagine-linked glycosylation 8 (alpha-1,3-glucosyltransferase) |
15036 |
0.13 |
chr18_74294664_74294815 | 8.85 |
Cfap53 |
cilia and flagella associated protein 53 |
219 |
0.92 |
chr11_96318827_96319554 | 8.81 |
Hoxb4 |
homeobox B4 |
923 |
0.28 |
chr17_79609796_79610102 | 8.80 |
Rmdn2 |
regulator of microtubule dynamics 2 |
1914 |
0.43 |
chr6_42363179_42363495 | 8.80 |
2010310C07Rik |
RIKEN cDNA 2010310C07 gene |
7334 |
0.09 |
chr15_81081388_81081539 | 8.77 |
Mrtfa |
myocardin related transcription factor A |
14451 |
0.15 |
chr7_45103031_45103408 | 8.74 |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
133 |
0.83 |
chr5_33542035_33542598 | 8.70 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr13_62952253_62952404 | 8.66 |
Gm48812 |
predicted gene, 48812 |
2886 |
0.22 |
chr13_43231981_43232458 | 8.64 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr12_91383684_91384259 | 8.64 |
Cep128 |
centrosomal protein 128 |
382 |
0.63 |
chr10_69253249_69253618 | 8.63 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
12204 |
0.19 |
chr6_86130065_86130447 | 8.63 |
Gm19596 |
predicted gene, 19596 |
16896 |
0.14 |
chr2_60940262_60940686 | 8.62 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22718 |
0.21 |
chr7_123124985_123125136 | 8.61 |
Tnrc6a |
trinucleotide repeat containing 6a |
804 |
0.68 |
chr5_74062664_74062828 | 8.60 |
Gm43415 |
predicted gene 43415 |
2708 |
0.15 |
chr15_76545778_76546051 | 8.60 |
Slc52a2 |
solute carrier protein 52, member 2 |
6950 |
0.07 |
chr2_12019857_12020050 | 8.60 |
Gm13310 |
predicted gene 13310 |
64039 |
0.11 |
chr1_168268952_168269254 | 8.57 |
Gm37524 |
predicted gene, 37524 |
68568 |
0.12 |
chr10_81095067_81095218 | 8.57 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
2567 |
0.11 |
chr1_191855059_191855511 | 8.55 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
28137 |
0.12 |
chr11_32280743_32280902 | 8.53 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
2689 |
0.14 |
chr8_128688109_128688260 | 8.53 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
2314 |
0.29 |
chr8_20817574_20818579 | 8.51 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr1_136465841_136466127 | 8.49 |
Kif14 |
kinesin family member 14 |
359 |
0.84 |
chr6_72552548_72553107 | 8.49 |
Capg |
capping protein (actin filament), gelsolin-like |
111 |
0.94 |
chr3_79144987_79146081 | 8.46 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
341 |
0.91 |
chr1_84960126_84960364 | 8.44 |
AC167036.1 |
novel protein |
1263 |
0.35 |
chr11_35572283_35572434 | 8.44 |
Slit3 |
slit guidance ligand 3 |
27673 |
0.2 |
chr3_108771125_108771338 | 8.43 |
Aknad1 |
AKNA domain containing 1 |
11017 |
0.15 |
chr19_7605885_7606822 | 8.42 |
Lgals12 |
lectin, galactose binding, soluble 12 |
750 |
0.59 |
chr15_95859172_95859323 | 8.42 |
Gm25070 |
predicted gene, 25070 |
20570 |
0.14 |
chr13_63039019_63039172 | 8.41 |
Aopep |
aminopeptidase O |
23602 |
0.15 |
chr11_117780269_117780842 | 8.41 |
Tmc6 |
transmembrane channel-like gene family 6 |
66 |
0.93 |
chr4_32486633_32487096 | 8.38 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
14641 |
0.23 |
chr5_14987708_14988443 | 8.35 |
Gm10354 |
predicted gene 10354 |
9140 |
0.21 |
chr6_146981244_146981874 | 8.30 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr16_26041382_26041987 | 8.28 |
AU015336 |
expressed sequence AU015336 |
416 |
0.88 |
chr2_125122926_125123420 | 8.25 |
Myef2 |
myelin basic protein expression factor 2, repressor |
241 |
0.89 |
chr9_59310966_59311172 | 8.24 |
Adpgk |
ADP-dependent glucokinase |
579 |
0.77 |
chr13_56747606_56747757 | 8.21 |
Gm45623 |
predicted gene 45623 |
6146 |
0.23 |
chr10_94574788_94575101 | 8.20 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
313 |
0.87 |
chr8_126736428_126737199 | 8.18 |
Gm45805 |
predicted gene 45805 |
21521 |
0.23 |
chr11_50713985_50714136 | 8.18 |
Gm12199 |
predicted gene 12199 |
4855 |
0.18 |
chr11_3170338_3170795 | 8.16 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
138 |
0.93 |
chr1_136007664_136007912 | 8.13 |
Tmem9 |
transmembrane protein 9 |
362 |
0.78 |
chr3_52938291_52938546 | 8.10 |
Gm20750 |
predicted gene, 20750 |
10752 |
0.18 |
chr12_59095476_59095647 | 8.08 |
Mia2 |
MIA SH3 domain ER export factor 2 |
238 |
0.83 |
chr12_29698179_29698919 | 8.08 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
12104 |
0.29 |
chr9_124425359_124425530 | 8.07 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1290 |
0.39 |
chr2_155894386_155894537 | 8.01 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
16143 |
0.11 |
chr1_166002288_166003185 | 7.98 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr13_95525489_95525667 | 7.97 |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
351 |
0.85 |
chr10_80164460_80165352 | 7.95 |
Cirbp |
cold inducible RNA binding protein |
1079 |
0.28 |
chr11_87056483_87056634 | 7.95 |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
17504 |
0.1 |
chr19_56099822_56100008 | 7.94 |
Gm31912 |
predicted gene, 31912 |
6333 |
0.26 |
chr2_181487275_181488108 | 7.93 |
Abhd16b |
abhydrolase domain containing 16B |
5515 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 15.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
3.6 | 10.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.6 | 14.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
3.3 | 13.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.8 | 8.4 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.7 | 8.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.7 | 13.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.6 | 7.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.6 | 12.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.5 | 7.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
2.4 | 14.5 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
2.4 | 4.8 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.3 | 6.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
2.3 | 6.9 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
2.3 | 6.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.0 | 8.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
2.0 | 5.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.9 | 5.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.9 | 5.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.7 | 8.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.7 | 5.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.7 | 11.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.7 | 1.7 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.6 | 6.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.6 | 4.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.6 | 4.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.6 | 3.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.5 | 35.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.5 | 4.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.5 | 4.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.5 | 7.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.5 | 4.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.5 | 4.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.4 | 5.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.4 | 4.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.4 | 6.8 | GO:0046618 | drug export(GO:0046618) |
1.3 | 5.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.3 | 8.0 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
1.3 | 5.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.3 | 5.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.3 | 2.5 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.3 | 6.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.2 | 3.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 4.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.2 | 3.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.2 | 3.6 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.2 | 7.2 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 2.4 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.2 | 5.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.2 | 2.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.2 | 3.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.2 | 3.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.2 | 4.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.1 | 3.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.1 | 4.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.1 | 4.5 | GO:0007296 | vitellogenesis(GO:0007296) |
1.1 | 3.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.1 | 2.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
1.1 | 2.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 2.2 | GO:0045472 | response to ether(GO:0045472) |
1.1 | 1.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.1 | 7.8 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.1 | 3.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.1 | 5.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 3.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.1 | 3.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.1 | 4.3 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.1 | 7.6 | GO:0060613 | fat pad development(GO:0060613) |
1.1 | 3.2 | GO:0040031 | snRNA modification(GO:0040031) |
1.1 | 3.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.1 | 3.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.1 | 6.4 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.0 | 2.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.0 | 7.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.0 | 4.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 9.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.0 | 2.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.0 | 4.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.0 | 4.0 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.0 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.0 | 5.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 2.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.0 | 2.9 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.9 | 2.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.9 | 1.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.9 | 3.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.9 | 2.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 2.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 5.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.9 | 2.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.9 | 2.8 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.9 | 2.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 8.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.9 | 2.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 5.4 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.9 | 16.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.9 | 9.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.9 | 2.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.9 | 0.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.9 | 7.1 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.9 | 2.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.9 | 4.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.9 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.9 | 1.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.9 | 0.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.9 | 0.9 | GO:0070836 | caveola assembly(GO:0070836) |
0.9 | 2.6 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 0.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.8 | 2.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.8 | 14.1 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.8 | 1.6 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.8 | 1.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.8 | 1.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 3.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.8 | 1.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.8 | 1.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.8 | 4.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 12.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.8 | 0.8 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 2.4 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 2.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 3.2 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 2.4 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 3.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 2.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.8 | 3.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.8 | 3.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 2.3 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.8 | 9.9 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.8 | 3.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 3.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 4.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 5.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.8 | 3.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.7 | 7.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 2.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.7 | 2.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 3.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.7 | 2.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.7 | 13.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.7 | 2.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 4.4 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 3.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 4.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 2.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 2.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 4.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.7 | 2.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.7 | 10.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.7 | 1.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.7 | 2.8 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.7 | 3.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 1.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 3.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 2.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.7 | 2.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.7 | 3.4 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 2.7 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.7 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 6.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.7 | 1.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.7 | 3.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 2.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 3.3 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.7 | 2.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.7 | 0.7 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.6 | 3.9 | GO:0075522 | IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
0.6 | 1.3 | GO:0048382 | mesendoderm development(GO:0048382) |
0.6 | 3.2 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.6 | 3.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.6 | 2.5 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
0.6 | 5.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.6 | 1.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 3.2 | GO:0009650 | UV protection(GO:0009650) |
0.6 | 3.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 2.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 4.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.6 | 1.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 2.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.6 | 1.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.6 | 3.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 4.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.6 | 1.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.6 | 6.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.6 | 6.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 0.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.6 | 0.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.6 | 1.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.6 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.6 | 2.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.6 | 1.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.6 | 1.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 1.8 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.6 | 2.4 | GO:0019230 | proprioception(GO:0019230) |
0.6 | 15.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.6 | 2.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.6 | 2.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 3.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 2.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 2.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 6.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.6 | 2.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 5.2 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.6 | 1.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.6 | 2.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.6 | 1.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.6 | 1.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 2.3 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 5.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.6 | 2.9 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.6 | 0.6 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.6 | 0.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.6 | 2.8 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.6 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 6.2 | GO:0007614 | short-term memory(GO:0007614) |
0.6 | 1.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 2.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 7.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 1.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 9.9 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 1.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 3.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 2.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 1.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 2.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.5 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 1.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 1.1 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 5.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.5 | 1.1 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.5 | 2.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 1.6 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.5 | 3.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 0.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.5 | 2.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 2.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.5 | 2.6 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.5 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 4.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 0.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 1.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 3.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.5 | 8.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.5 | 1.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 2.5 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 2.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.5 | 1.0 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.5 | 1.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.5 | 1.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 0.5 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.5 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 2.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 1.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.5 | 5.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.5 | 1.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 1.5 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 1.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 4.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.5 | 1.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 2.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 2.9 | GO:0051645 | Golgi localization(GO:0051645) |
0.5 | 3.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 2.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 1.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 4.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 2.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 8.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 2.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 1.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 3.4 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.5 | 0.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.5 | 1.4 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.5 | 1.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 1.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 20.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.5 | 2.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 1.9 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 2.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.5 | 2.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.9 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.5 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 2.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 0.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.5 | 15.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.5 | 0.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 3.6 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 2.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.5 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 4.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 4.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.4 | 0.9 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 2.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 0.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 3.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.4 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 6.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 3.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 0.4 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.4 | 1.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 0.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 1.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.4 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 0.9 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.4 | 0.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.4 | 0.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 3.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 1.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 0.4 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 0.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.4 | 2.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 4.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 4.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 2.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.6 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.4 | 0.8 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.4 | 1.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.4 | 0.4 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 6.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.4 | 4.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 1.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 1.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 2.0 | GO:0042905 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 0.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 4.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 2.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 1.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.4 | 2.8 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.4 | 0.8 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.4 | 0.8 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.4 | 2.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 3.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 3.9 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 1.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 1.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.4 | 2.3 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.4 | 1.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.4 | 1.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 1.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.4 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 1.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 5.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.4 | 0.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 18.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 0.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.4 | 1.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 0.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.4 | 3.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 2.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.4 | 3.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.4 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 2.6 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.4 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 0.4 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.4 | 1.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 1.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 0.7 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.4 | 5.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.4 | 1.1 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.4 | 6.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 0.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 1.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 1.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 0.7 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 1.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 0.7 | GO:0071694 | sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 2.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 2.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 3.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 19.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.3 | 0.3 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.3 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.7 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 4.8 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 7.8 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.3 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 1.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 1.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 0.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 0.3 | GO:0043217 | myelin maintenance(GO:0043217) |
0.3 | 1.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 3.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.3 | 5.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 2.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 4.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 1.0 | GO:0021546 | rhombomere development(GO:0021546) |
0.3 | 0.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 3.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.3 | 1.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 1.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 1.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 1.9 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 2.2 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.3 | 0.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.3 | 0.3 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 1.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.3 | 1.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.3 | 1.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 1.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 12.9 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 4.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 3.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 1.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 0.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 0.3 | GO:0043084 | penile erection(GO:0043084) |
0.3 | 0.6 | GO:0036507 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 0.3 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 13.3 | GO:0003341 | cilium movement(GO:0003341) |
0.3 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.9 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 0.9 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 4.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 2.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 1.5 | GO:1903671 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.3 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 1.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.2 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 1.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.3 | 0.9 | GO:0030540 | female genitalia development(GO:0030540) vagina development(GO:0060068) |
0.3 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.3 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.9 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.9 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 3.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.3 | 1.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.3 | 1.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.3 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.9 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.3 | 2.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 2.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 0.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 1.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 0.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.3 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 0.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 0.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 16.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 3.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.6 | GO:0045714 | regulation of low-density lipoprotein particle clearance(GO:0010988) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.3 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.3 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 1.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 2.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 2.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 7.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.8 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 2.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.8 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 8.0 | GO:0007569 | cell aging(GO:0007569) |
0.3 | 5.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 0.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 0.8 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.5 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.3 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 2.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.3 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 2.4 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 1.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 0.8 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.3 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 3.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 1.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 1.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 0.8 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 12.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 0.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.5 | GO:2000767 | regulation of cytoplasmic translation(GO:2000765) positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 1.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 2.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 0.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.3 | 0.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.3 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 1.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 1.8 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.3 | 1.3 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 0.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 3.8 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
0.3 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 0.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 0.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 1.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.2 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 1.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.2 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 1.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 5.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 1.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 2.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 1.9 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 1.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 2.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 1.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 7.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 1.2 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.2 | 1.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.7 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 0.7 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 0.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 3.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 2.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 6.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 0.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 1.6 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 2.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 1.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 2.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.9 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.2 | 4.8 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 1.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 5.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.7 | GO:0001889 | liver development(GO:0001889) |
0.2 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.7 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 0.7 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 2.7 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 0.4 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
0.2 | 2.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 3.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.2 | GO:2000974 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.2 | 0.9 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.2 | 0.4 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.2 | 1.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.2 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 4.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.4 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.2 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 0.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 2.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 0.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.2 | 0.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 0.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 1.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.4 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.2 | 1.3 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 3.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 1.5 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.2 | 0.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 1.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 1.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 1.5 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.2 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.0 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.4 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 0.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.4 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.2 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 7.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 0.2 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.2 | 0.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.2 | 1.8 | GO:0045216 | cell-cell junction organization(GO:0045216) |
0.2 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 1.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.2 | 0.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.8 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 0.4 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 2.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 2.6 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.2 | 0.4 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.2 | 0.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.6 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.2 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 1.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.2 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 5.1 | GO:0006096 | glycolytic process(GO:0006096) |
0.2 | 0.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 0.4 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 2.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 2.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 6.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.6 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 2.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 1.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 4.4 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.2 | 1.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 1.7 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 2.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 1.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 1.0 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.2 | 0.8 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.2 | 0.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.2 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.2 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.2 | 0.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.4 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.2 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 6.1 | GO:0030282 | bone mineralization(GO:0030282) |
0.2 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.2 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.2 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.2 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.9 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.2 | 1.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 1.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.2 | 0.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 2.2 | GO:0001947 | heart looping(GO:0001947) |
0.2 | 4.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 1.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.2 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 3.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 6.4 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 1.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.4 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 1.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 1.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 1.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 1.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.7 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 2.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 1.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.2 | 1.9 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.7 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 1.6 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 2.6 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 0.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.3 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 1.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 1.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 1.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.5 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 2.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 3.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 4.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 1.0 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 17.7 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.3 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.2 | 0.5 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) regulation of ceramide biosynthetic process(GO:2000303) |
0.2 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 1.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.3 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.2 | 4.3 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.2 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 5.7 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 4.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 1.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 4.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.2 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 1.2 | GO:0009451 | RNA modification(GO:0009451) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 1.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.3 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.2 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 2.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 0.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 3.2 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 4.0 | GO:0034329 | cell junction assembly(GO:0034329) |
0.2 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.3 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 1.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 0.3 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.2 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.3 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 2.7 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.7 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 1.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 7.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 1.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 1.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 6.5 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.7 | GO:0051302 | regulation of cell division(GO:0051302) |
0.1 | 3.4 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.4 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) |
0.1 | 0.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 8.0 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 1.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.7 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 4.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.4 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 1.7 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.4 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.1 | 30.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 5.4 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 1.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 2.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.6 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.7 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 7.9 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.1 | 0.3 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.3 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.3 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 1.4 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.4 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 2.4 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 2.6 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.1 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.4 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.5 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.3 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 1.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 1.0 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.1 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 7.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.4 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 1.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 2.4 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.6 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 1.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) quinone biosynthetic process(GO:1901663) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 3.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 10.8 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 1.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.1 | 3.5 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.7 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.9 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 1.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.8 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 1.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 2.8 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.9 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.1 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 1.3 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.5 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 1.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.2 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.3 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 1.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.3 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 1.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 1.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 7.7 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.8 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 7.3 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.7 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.6 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.3 | GO:0009179 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.1 | 0.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.4 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 1.0 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.5 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 5.5 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.1 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 1.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 4.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.7 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.7 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 3.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.4 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.6 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.1 | 0.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.7 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.1 | GO:0090656 | t-circle formation(GO:0090656) regulation of t-circle formation(GO:1904429) |
0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 1.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.6 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.3 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 1.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 6.0 | GO:0010498 | proteasomal protein catabolic process(GO:0010498) |
0.1 | 0.1 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.1 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.1 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.2 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 2.0 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.6 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 1.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.7 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.1 | 0.4 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.9 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 2.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.2 | GO:1904375 | regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.1 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.9 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.1 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.9 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.6 | GO:0006639 | acylglycerol metabolic process(GO:0006639) |
0.1 | 0.5 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.5 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.1 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 1.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.1 | 3.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 2.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.5 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.1 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.5 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 1.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.1 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 1.3 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.1 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:0046471 | cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.8 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 1.0 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 1.3 | GO:0009799 | specification of symmetry(GO:0009799) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.6 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.3 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.1 | 0.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.3 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.1 | 0.3 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.1 | 0.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.3 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.1 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.1 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.6 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.6 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.1 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.1 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.1 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 1.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.7 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.7 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 1.9 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 0.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.1 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) regulation of transcription by glucose(GO:0046015) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.3 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 1.6 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.9 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.1 | GO:0090160 | regulation of natural killer cell degranulation(GO:0043321) Golgi to lysosome transport(GO:0090160) |
0.1 | 0.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.5 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.3 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.4 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.1 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.1 | 0.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.5 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.2 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 3.9 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 3.0 | GO:0050817 | coagulation(GO:0050817) |
0.1 | 0.2 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.4 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.7 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.3 | GO:0009411 | response to UV(GO:0009411) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:0007620 | copulation(GO:0007620) |
0.1 | 5.5 | GO:0009617 | response to bacterium(GO:0009617) |
0.1 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.9 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.1 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 1.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 2.8 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.1 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.1 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0098586 | cellular response to virus(GO:0098586) |
0.1 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 1.3 | GO:0034470 | ncRNA processing(GO:0034470) |
0.1 | 0.3 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 0.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 4.2 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.1 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.5 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.7 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0014061 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.0 | 0.0 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.5 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 3.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.7 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.0 | 0.5 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 6.3 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.0 | GO:0006598 | polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 1.9 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0002709 | regulation of T cell mediated immunity(GO:0002709) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.0 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.0 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:2000846 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.0 | GO:0097205 | renal filtration(GO:0097205) |
0.0 | 0.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.0 | 0.0 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.0 | 0.0 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 1.4 | GO:0000280 | nuclear division(GO:0000280) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.0 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.0 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 3.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.0 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.3 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.2 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 1.6 | GO:0070085 | glycosylation(GO:0070085) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.0 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 1.4 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 2.9 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.0 | 0.0 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 1.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.0 | GO:0006403 | RNA localization(GO:0006403) |
0.0 | 0.0 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.2 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0071560 | cellular response to transforming growth factor beta stimulus(GO:0071560) |
0.0 | 0.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.0 | GO:1903708 | positive regulation of hemopoiesis(GO:1903708) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:0046467 | membrane lipid biosynthetic process(GO:0046467) |
0.0 | 0.0 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.0 | 0.0 | GO:0002701 | negative regulation of production of molecular mediator of immune response(GO:0002701) |
0.0 | 0.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.2 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.0 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.0 | 0.2 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.0 | 0.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 2.0 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.0 | GO:0098754 | detoxification(GO:0098754) |
0.0 | 0.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 15.0 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.0 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.0 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.1 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.2 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.8 | GO:0097413 | Lewy body(GO:0097413) |
2.2 | 8.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.1 | 6.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.1 | 2.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.0 | 6.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.0 | 30.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.6 | 4.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.5 | 10.3 | GO:0090543 | Flemming body(GO:0090543) |
1.4 | 7.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.4 | 4.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 5.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.4 | 6.8 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.3 | 2.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.2 | 4.8 | GO:0097452 | GAIT complex(GO:0097452) |
1.1 | 17.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.1 | 3.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.1 | 6.6 | GO:0070847 | core mediator complex(GO:0070847) |
1.1 | 4.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.1 | 3.3 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 15.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
1.0 | 2.9 | GO:0000811 | GINS complex(GO:0000811) |
1.0 | 2.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.9 | 11.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.9 | 3.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.9 | 10.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 2.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 6.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.9 | 6.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 2.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 2.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.8 | 3.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.8 | 5.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 4.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 17.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 4.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 10.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.7 | 2.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.7 | 2.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 6.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 17.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.7 | 2.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 3.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.7 | 2.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.7 | 3.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.7 | 5.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 8.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 2.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 1.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 12.0 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.6 | 5.0 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 3.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.6 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 1.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 4.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 2.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 3.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 2.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 5.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 5.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 5.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 1.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 2.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 5.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.5 | 4.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 2.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 3.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 4.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 2.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 1.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 2.4 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 2.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 1.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 14.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.5 | 3.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 5.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.5 | 0.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.5 | 8.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 6.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 2.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 2.5 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 0.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 6.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 0.4 | GO:0005912 | adherens junction(GO:0005912) |
0.4 | 1.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 1.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.4 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 6.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 2.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 1.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 4.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 4.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.4 | 2.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.4 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 2.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 5.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 2.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 2.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 10.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 2.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.7 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.3 | 18.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 6.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 2.8 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 4.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 1.2 | GO:0005818 | aster(GO:0005818) |
0.3 | 2.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 4.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 2.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 10.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.9 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 5.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 7.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 2.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 5.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 3.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 2.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 2.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 1.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 27.7 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 2.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 9.3 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 2.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 1.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 5.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 7.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 0.8 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 0.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 96.6 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 3.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 10.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 4.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 10.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 1.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 13.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.5 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 11.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.2 | 1.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 5.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.9 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.2 | 0.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 2.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 1.5 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 4.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 1.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 3.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 11.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.6 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.2 | 1.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.3 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 4.0 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 1.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 1.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 63.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 2.7 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 26.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 2.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 4.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 1.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.5 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.2 | 4.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 1.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 7.7 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.7 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 55.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 6.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.0 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 8.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.4 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 3.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 1.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 4.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 2.2 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 207.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.0 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 3.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 11.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 9.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.8 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.2 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 1.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 5.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 5.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.4 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.2 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 2.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 239.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 14.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 7.2 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 1.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 3.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 2.0 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 12.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 96.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.8 | GO:0030496 | midbody(GO:0030496) |
0.1 | 38.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 67.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0031674 | I band(GO:0031674) |
0.1 | 3.7 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.8 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.1 | 2.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 1.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 42.1 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 2.9 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 3.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 4.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.2 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 1.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 10.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 3.4 | GO:0031975 | envelope(GO:0031975) |
0.1 | 1.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.4 | GO:0005819 | spindle(GO:0005819) |
0.1 | 3.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 3.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0031390 | DNA replication factor C complex(GO:0005663) Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 1.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 114.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 1.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 20.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 1.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 5.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 53.0 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.0 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 78.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.0 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 9.8 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.0 | 9.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.9 | 11.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.7 | 8.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.5 | 7.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.2 | 42.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.2 | 13.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.1 | 15.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.1 | 8.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
2.0 | 10.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.8 | 7.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.8 | 5.3 | GO:0048030 | disaccharide binding(GO:0048030) |
1.7 | 10.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 6.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.5 | 11.7 | GO:0008430 | selenium binding(GO:0008430) |
1.4 | 7.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.4 | 9.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.3 | 5.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 3.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.3 | 3.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.3 | 6.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.3 | 3.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.2 | 4.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.2 | 5.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.2 | 3.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.2 | 4.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.2 | 13.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.1 | 6.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.1 | 4.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.0 | 5.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 5.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.0 | 3.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.0 | 3.9 | GO:0009374 | biotin binding(GO:0009374) |
1.0 | 2.9 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 7.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.0 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.0 | 3.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.9 | 5.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.9 | 7.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.9 | 9.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.9 | 3.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 4.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.9 | 2.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.9 | 2.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 4.3 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 2.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.8 | 4.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 4.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.8 | 9.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.8 | 7.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.8 | 2.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 2.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 5.8 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.8 | 3.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 4.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 2.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 3.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 1.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.8 | 6.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 7.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.7 | 5.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 1.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.7 | 2.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.7 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 2.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.7 | 14.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.7 | 2.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 3.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 3.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.7 | 3.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 22.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 2.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.7 | 6.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 5.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.7 | 2.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.7 | 2.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 4.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.7 | 6.0 | GO:0052686 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.7 | 1.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 2.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 2.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 8.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 4.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.6 | 2.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.6 | 5.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 1.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 1.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 1.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 5.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 5.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 3.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.6 | 9.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 3.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 1.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 15.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.6 | 1.8 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 1.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 1.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.6 | 1.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 1.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 3.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 6.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 16.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.6 | 2.9 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.6 | 1.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 1.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 19.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 4.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 1.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.6 | 3.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 23.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.6 | 2.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.6 | 2.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 8.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.6 | 2.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 1.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 2.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 3.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 1.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 1.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.5 | 2.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.5 | 1.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.5 | 2.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 1.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 4.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 1.9 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 1.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.5 | 3.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 2.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 3.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 1.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 2.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 3.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.4 | 1.8 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 5.7 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 1.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 7.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 4.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 5.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 1.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 10.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.4 | 1.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 5.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 2.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 1.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 3.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 11.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.4 | 3.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 1.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 2.0 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 5.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 2.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 3.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 2.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 3.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 0.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 2.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 5.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 5.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 5.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 2.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 3.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 7.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 4.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 12.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.4 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 2.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 2.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 6.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.4 | 0.7 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.4 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 15.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.4 | 3.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 7.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 4.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 1.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 3.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 6.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 7.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 1.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 3.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 2.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 3.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 1.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 2.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 6.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 3.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 2.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 2.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 3.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 3.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 3.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 1.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 2.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 0.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 0.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 2.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 2.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 2.9 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 6.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 2.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 1.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 3.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 2.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 3.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 0.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 60.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.3 | 1.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 2.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 1.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 5.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 3.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 3.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 7.9 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.3 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 3.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 1.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 3.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 1.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 5.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 2.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.5 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 9.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 3.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 3.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 11.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 3.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.5 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 5.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 40.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 7.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 6.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 1.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 3.7 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 6.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 2.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 1.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.2 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 20.6 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 1.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 3.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 1.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 4.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.8 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 7.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.4 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.2 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 6.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.6 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 4.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 13.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 3.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 1.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 1.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 1.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 28.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 2.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 3.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 2.3 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 1.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 9.1 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 2.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 2.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 2.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 5.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.8 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 2.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.9 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.2 | 9.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 2.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 5.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 4.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 3.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 1.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 2.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 11.9 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.5 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 4.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 2.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 2.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 17.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.8 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 4.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 2.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 3.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 3.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 7.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 4.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 30.7 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 2.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.5 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 11.6 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 5.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 2.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 2.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 3.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.4 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 2.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.4 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 1.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 6.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 3.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.8 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.1 | 1.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 11.0 | GO:0070737 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 6.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.6 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 62.1 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 8.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 6.4 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 4.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.3 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 4.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 15.7 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.1 | 24.7 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 6.0 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 2.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 1.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.8 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 4.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.3 | GO:0043121 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0016749 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 3.2 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 3.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 4.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.9 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 2.2 | GO:0000975 | regulatory region DNA binding(GO:0000975) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 27.9 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.1 | 1.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.9 | GO:0019842 | vitamin binding(GO:0019842) |
0.1 | 1.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.2 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 2.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 9.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 19.6 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 2.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 3.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 4.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.4 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 15.6 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.9 | GO:0022842 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 1.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.1 | 2.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.8 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.2 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 12.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 2.3 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.7 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 1.1 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 23.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 9.0 | GO:0032403 | protein complex binding(GO:0032403) |
0.1 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 9.0 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.3 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.3 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 2.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 7.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 21.9 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.1 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.2 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 20.0 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0016301 | kinase activity(GO:0016301) |
0.0 | 1.0 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.0 | 0.3 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 4.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 3.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.3 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 1.0 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.8 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.0 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 2.0 | GO:0005524 | ATP binding(GO:0005524) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 1.8 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 0.5 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.1 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 14.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.0 | GO:0051379 | epinephrine binding(GO:0051379) |
0.0 | 0.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.0 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.2 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0001968 | fibronectin binding(GO:0001968) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 11.9 | ST STAT3 PATHWAY | STAT3 Pathway |
1.2 | 9.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.0 | 13.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.8 | 21.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.8 | 18.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 24.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.7 | 20.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 12.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 38.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 3.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 7.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.5 | 13.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 8.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 5.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 3.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 4.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 6.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 5.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 13.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 3.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 3.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 17.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 9.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 10.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 10.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 3.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 3.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 1.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 8.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 8.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 6.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 7.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 5.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 1.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 5.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 6.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 2.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 2.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 4.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 2.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 2.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 1.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 5.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 0.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 1.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 2.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 5.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 3.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 7.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 5.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 4.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 3.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 4.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 7.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 4.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 2.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 6.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 3.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 7.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 3.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 4.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 5.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 2.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 14.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 4.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 5.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 3.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 1.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 1.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 4.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 1.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 3.1 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 2.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 12.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.0 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 8.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 5.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.2 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 13.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.3 | 11.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.1 | 8.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.0 | 16.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 9.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.0 | 1.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.8 | 1.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 11.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.8 | 11.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.7 | 8.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.7 | 7.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 3.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.7 | 9.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 6.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 11.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.6 | 13.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.6 | 6.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 7.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.6 | 5.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 10.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.6 | 9.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.6 | 10.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 6.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 6.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 4.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 5.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 5.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.5 | 6.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 2.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 2.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 4.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.5 | 12.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 1.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 2.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 3.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.5 | 6.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 5.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 5.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 4.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 7.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 4.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 2.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 1.3 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.4 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 0.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 6.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 4.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 10.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 3.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 6.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 9.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 18.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 7.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 3.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 7.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 7.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 7.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 3.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 7.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 1.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 1.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 22.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.4 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 5.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 4.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 8.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 8.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 4.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 2.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 6.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 1.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 1.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 5.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 15.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 8.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 2.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 4.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 4.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 1.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 2.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 2.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 4.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 4.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 14.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 5.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.6 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 2.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 8.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 12.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 1.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 9.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 4.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 2.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 9.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 7.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 5.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 7.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 11.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 5.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 5.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 3.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 5.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 2.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 2.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 2.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 2.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 1.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 1.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 1.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 1.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 2.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 2.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 3.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 2.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 13.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 12.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 22.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 5.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 1.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 14.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 3.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 2.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.3 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 4.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.5 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 3.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 8.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 5.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 2.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 1.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |